Active efflux, a common mechanism for biocide and antibiotic resistance, Journal of Applied Microbiology, vol.265, issue.s1, pp.65-71, 2002. ,
DOI : 10.1046/j.1365-2958.2000.02149.x
Efflux-Mediated Drug Resistance in Bacteria, Drugs, vol.182, issue.8, pp.159-204, 2004. ,
DOI : 10.2165/00003495-200464020-00004
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847397
Vacuuming the Periplasm, Journal of Bacteriology, vol.187, issue.6, pp.1879-83, 2005. ,
DOI : 10.1128/JB.187.6.1879-1883.2005
Efflux-mediated antimicrobial resistance, Journal of Antimicrobial Chemotherapy, vol.56, issue.1, pp.20-51, 2005. ,
DOI : 10.1093/jac/dki171
URL : http://jac.oxfordjournals.org/cgi/content/short/56/1/20
Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy, Journal of Antimicrobial Chemotherapy, vol.51, issue.5, pp.1055-65, 2003. ,
DOI : 10.1093/jac/dkg224
TolC - the bacterial exit duct for proteins and drugs, FEBS Letters, vol.5, issue.1 ,
DOI : 10.1016/S0014-5793(03)01125-6
Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria, Clinical Microbiology Reviews, vol.19, issue.2, pp.382-402, 2006. ,
DOI : 10.1128/CMR.19.2.382-402.2006
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1471989
Molecular Basis of Bacterial Outer Membrane Permeability Revisited, Microbiology and Molecular Biology Reviews, vol.67, issue.4, pp.593-656, 2003. ,
DOI : 10.1128/MMBR.67.4.593-656.2003
Role of Bacterial Porins in Antibiotic Susceptibility of Gram-Negative Bacteria, pp.41-59, 2004. ,
DOI : 10.1002/3527603875.ch3
Multidrug efflux pumps and resistance: regulation and evolution, Current Opinion in Microbiology, vol.6, issue.5, pp.446-51, 2003. ,
DOI : 10.1016/j.mib.2003.08.005
Tracing pathways of transport protein evolution, Molecular Microbiology, vol.1511, issue.5 ,
DOI : 10.1046/j.1365-2958.2003.03499.x
Three's company: component structures bring a closer view of tripartite drug efflux pumps, Current Opinion in Structural Biology, vol.14, issue.6, pp.741-748, 2004. ,
DOI : 10.1016/j.sbi.2004.10.003
Modeling the Tripartite Drug Efflux Pump Archetype: Structural and Functional Studies of the Macromolecular Constituents Reveal More Than Their Names Imply, Journal of Chemotherapy, vol.279, issue.31, pp.581-92, 2005. ,
DOI : 10.1016/j.bbrc.2004.07.140
Regulation of Bacterial Drug Export Systems, Microbiology and Molecular Biology Reviews, vol.66, issue.4, pp.671-701, 2002. ,
DOI : 10.1128/MMBR.66.4.671-701.2002
Antibiotic efflux pumps, Biochemical Pharmacology, vol.60, issue.4 ,
DOI : 10.1016/S0006-2952(00)00291-4
Mechanisms of Solvent Tolerance in Gram-Negative Bacteria, Annual Review of Microbiology, vol.56, issue.1, pp.743-68, 2002. ,
DOI : 10.1146/annurev.micro.56.012302.161038
Role of the AcrAB-TolC Efflux Pump in Determining Susceptibility of Haemophilus influenzae to the Novel Peptide Deformylase Inhibitor LBM415, Antimicrobial Agents and Chemotherapy, vol.49, issue.8, pp.3129-3164, 2005. ,
DOI : 10.1128/AAC.49.8.3129-3135.2005
Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus, Nature, vol.437, issue.7061, pp.975-80, 2005. ,
DOI : 10.1038/nature04051
Platensimycin is a selective FabF inhibitor with potent antibiotic properties, Nature, vol.50, issue.7091, pp.358-61, 2006. ,
DOI : 10.1016/0022-2836(71)90324-X
In search of natural substrates and inhibitors of MDR pumps Efflux pumps: their role in antibacterial drug discovery, J Mol Microbiol Biotechnol Curr Med Chem, vol.3, issue.8, pp.247-54, 2001. ,
Bacterial efflux pump inhibition, Curr Opin Investig Drugs, vol.6, pp.191-199, 2005. ,
Inhibitors of efflux pumps in Gram-negative bacteria, Practical applications and feasibility of efflux pump inhibitors in the clinic?a vision for applied use, pp.382-391, 2005. ,
DOI : 10.1016/j.molmed.2005.06.006
Inhibitors of Bacterial Efflux Pumps as Adjuvants in Antibiotic Treatments and Diagnostic Tools for Detection of Resistance by Efflux, Recent Patents on Anti-Infective Drug Discovery, vol.1, issue.2, 2006. ,
DOI : 10.2174/157489106777452692
Ciprofloxacin-Resistant Salmonella enterica Serovar Typhimurium Strains Are Difficult To Select in the Absence of AcrB and TolC, Antimicrobial Agents and Chemotherapy, vol.50, issue.1, pp.38-42, 2006. ,
DOI : 10.1128/AAC.50.1.38-42.2006
Role of the CmeABC efflux pump in the emergence of fluoroquinolone-resistant Campylobacter under selection pressure, Journal of Antimicrobial Chemotherapy, vol.58, issue.6, pp.1154-1163, 2006. ,
DOI : 10.1093/jac/dkl412
Neopeptide Antibiotics That Function as Opsonins and Membrane-Permeabilizing Agents for Gram-Negative Bacteria, Antimicrobial Agents and Chemotherapy, vol.49, issue.8, pp.3122-3130, 2005. ,
DOI : 10.1128/AAC.49.8.3122-3128.2005
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1196242
Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar Typhimurium, Molecular Microbiology, vol.67, issue.1, pp.126-167, 2006. ,
DOI : 10.1073/pnas.0408238102
Crystal structures of a multidrug transporter reveal a functionally rotating mechanism, Nature, vol.55, issue.7108, pp.173-182, 2006. ,
DOI : 10.1038/nature05076
Structural Asymmetry of AcrB Trimer Suggests a Peristaltic Pump Mechanism, Science, vol.313, issue.5791, pp.1295-1303, 2006. ,
DOI : 10.1126/science.1131542
Structural biology: The ins and outs of drug transport, Nature, vol.308, issue.7108, pp.156-163, 2006. ,
DOI : 10.1038/443156b
Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes, Microbiology, vol.144, issue.11, pp.3003-3012, 1998. ,
DOI : 10.1099/00221287-144-11-3003
Active efflux of bile salts by Escherichia coli., Journal of Bacteriology, vol.179, issue.8, pp.2512-2530, 1997. ,
DOI : 10.1128/jb.179.8.2512-2518.1997
Potentiate the Activity of the Fluoroquinolone Antibacterial Levofloxacin, Journal of Medicinal Chemistry, vol.42, issue.24, pp.4928-4959, 1999. ,
DOI : 10.1021/jm9904598
Use of an Efflux Pump Inhibitor To Determine the Prevalence of Efflux Pump-Mediated Fluoroquinolone Resistance and Multidrug Resistance in Pseudomonas aeruginosa, Antimicrobial Agents and Chemotherapy, vol.49, issue.2, pp.565-70, 2005. ,
DOI : 10.1128/AAC.49.2.565-570.2005
A Periplasmic Drug-Binding Site of the AcrB Multidrug Efflux Pump: a Crystallographic and Site-Directed Mutagenesis Study, Journal of Bacteriology, vol.187, issue.19, pp.6804-6819, 2005. ,
DOI : 10.1128/JB.187.19.6804-6815.2005
Structural Basis of Multiple Drug-Binding Capacity of the AcrB Multidrug Efflux Pump, Science, vol.300, issue.5621, pp.976-80, 2003. ,
DOI : 10.1126/science.1083137
Conformationally-restricted analogues of efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa, Bioorganic & Medicinal Chemistry Letters, vol.13, issue.16, pp.2755-2763, 2003. ,
DOI : 10.1016/S0960-894X(03)00556-0
Addressing the stability of C-capped dipeptide efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa, Bioorganic & Medicinal Chemistry Letters, vol.11, issue.5, pp.663-670, 2001. ,
DOI : 10.1016/S0960-894X(01)00033-6
The relationship between physicochemical properties, In vitro activity and pharmacokinetic profiles of analogues of diamine-Containing efflux pump inhibitors, Bioorganic & Medicinal Chemistry Letters, vol.13, issue.23 ,
DOI : 10.1016/j.bmcl.2003.07.030
Peptidomimetics of Efflux Pump Inhibitors Potentiate the Activity of Levofloxacin in Pseudomonas aeruginosa, Bioorganic & Medicinal Chemistry Letters, vol.12, issue.5, pp.763-769, 2002. ,
DOI : 10.1016/S0960-894X(02)00006-9
Part 2: achieving activity in vivo through the use of alternative scaffolds MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa Part 3: Optimization of potency in the pyridopyrimidine series through the application of a pharmacophore model Addressing the problem of poor stability due to photoisomerization of an acrylic acid moiety, efflux pump inhibitors in Pseudomonas aeruginosa MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa, pp.4205-4213, 2003. ,
MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 6: Exploration of aromatic substituents Quinolone derivatives as promising inhibitors of antibiotic efflux pump in multidrug resistant Enterobacter aerogenes, Carbon-substituted analogues at the C-2 position, pp.1993-2004, 2006. ,
DOI : 10.1016/j.bmc.2006.08.037
Strains, Journal of Medicinal Chemistry, vol.44, issue.23, pp.4023-4029, 2001. ,
DOI : 10.1021/jm010911z
URL : https://hal.archives-ouvertes.fr/hal-00450930
4-alkoxy and 4-thioalkoxyquinoline derivatives as chemosensitizers for the chloramphenicol-resistant clinical Enterobacter aerogenes 27 strain, International Journal of Antimicrobial Agents, vol.22, issue.3, pp.801-806, 2003. ,
DOI : 10.1016/S0924-8579(03)00215-2
Inhibitors of Antibiotic Efflux in Resistant Enterobacter aerogenes and Klebsiella pneumoniae Strains, Antimicrobial Agents and Chemotherapy, vol.48, issue.3, pp.1043-1049, 2004. ,
DOI : 10.1128/AAC.48.3.1043-1046.2004
Chloroquinolines block antibiotic efflux pumps in antibiotic-resistant Enterobacter aerogenes isolates, International Journal of Antimicrobial Agents, vol.27, issue.6, pp.565-574, 2006. ,
DOI : 10.1016/j.ijantimicag.2006.03.010
MexAB-OprM specific 58 ,
Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureus, International Journal of Antimicrobial Agents, vol.22, issue.3, pp.254-61, 2003. ,
DOI : 10.1016/S0924-8579(03)00220-6
Selected Arylpiperazines Are Capable of Reversing Multidrug Resistance in Escherichia coli Overexpressing RND Efflux Pumps, MexAB-OprM specific Enterobacteriaceae other than Escherichia coli. J Antimicrob efflux pump inhibitors in Pseudomonas aeruginosa. Part, pp.849-52, 2005. ,
DOI : 10.1128/AAC.49.2.849-852.2005
Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli, Journal of Antimicrobial Chemotherapy, vol.57, issue.2, pp.339-382, 2006. ,
DOI : 10.1093/jac/dki445
Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-??-naphthylamide, Journal of Antimicrobial Chemotherapy, vol.57, issue.5 ,
DOI : 10.1093/jac/dkl081
URL : http://jac.oxfordjournals.org/cgi/content/short/57/5/970
Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclines, Journal of Medicinal Chemistry, vol.36, issue.3, pp.370-377, 1993. ,
DOI : 10.1021/jm00055a008
Molecular Requirements for the Inhibition of the Tetracycline Antiport Protein and the Effect of Potent Inhibitors on the Growth of Tetracycline-Resistant Bacteria, Journal of Medicinal Chemistry, vol.37, issue.9, pp.1355-61, 1994. ,
DOI : 10.1021/jm00035a016
Reversal of tetracycline resistance ,
Alkylaminoquinolines mediated by different bacterial tetracycline resistance determinants by inhibit bacterial antibiotic efflux pump in multidrug resistant clinical an inhibitor of the Tet(B) antiport protein, Antimicrob Agents Chemother, vol.43, pp.1719-1743, 1999. ,
Inhibition of the transport funcefflux pump in resistant Enterobacter aerogenes and Klebsiella tion of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells, Anticancer Res, vol.17, pp.481-487, 1997. ,
Antimicrobial activity of phenothiazines, In Vivo, vol.18, pp.725-756, 2004. ,